VERIFIED QUOTE · reported 2025-07-19
“no new or changed safety signals”
Sarepta Therapeutics · said 2025-07-18 · reported 2025-07-19
Sarepta stated that its review showed no safety changes for younger patients receiving its Duchenne therapy.
This quote was mechanically extracted from the cited article and verified as an exact substring of the source text before publication. Attribution follows the article's own wording.